Sodium tanshinone IIA sulfonate and its interactions with human CYP450s

References

• Bourrie M, Meunier V, Berger Y, et al. (1996). Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes. J Pharmacol Exp Ther 277:321–32
   PubMed Web of Science ®Google Scholar
• Chen S, Zhao X, Li Y, et al. (2013). Impurities preparation of sodium tanshinone IIA sulfonate by high-speed counter-current chromatography and identification by liquid chromatography/multistage tandem mass spectrometry. J Chromatogr A 1288:28–34
   PubMed Web of Science ®Google Scholar
• Chen W, Tang F, Xie B, et al. (2012). Amelioration of atherosclerosis by tanshinone IIA in hyperlipidemic rabbits through attenuation of oxidative stress. Eur J Pharmacol 674:359–64
   PubMed Web of Science ®Google Scholar
• Chen Y, Tu JH, He YJ, et al. (2009). Effect of sodium tanshinone IIA sulfonate on the activity of CYP1A2 in healthy volunteers. Xenobiotica 39:508–13
   PubMed Web of Science ®Google Scholar
• Ching MS, Blake CL, Ghabrial H, et al. (1995). Potent inhibition of yeast-expressed CYP2D6 by dihydroquinidine, quinidine, and its metabolites. Biochem Pharmacol 50: 833-37
   PubMed Web of Science ®Google Scholar
• Dong X, Dong J, Zhang R, et al. (2009). Anti-inflammatory effects of tanshinone IIA on radiation-induced microglia BV-2 cells inflammatory response. Cancer Biother Radiopharm 24:681–7
   PubMed Web of Science ®Google Scholar
• Gebhardt AC, Lucas D, Menez JF, et al. (1997). Chlormethiazole inhibition of cytochrome P450 2E1 as assessed by chlorzoxazone hydroxylation in humans. Hepatology 26:957–961
   PubMed Web of Science ®Google Scholar
• Gervasini G, Garcia M, Macias RM, et al. (2012). Impact of genetic polymorphisms on tacrolimus pharmacokinetics and the clinical outcome of renal transplantation. Transpl Int 25:471–80
   PubMed Web of Science ®Google Scholar
• Hao H, Wang G, Cui N, et al. (2007). Determination of sodium tanshinone IIA sulfonate in plasma by liquid chromatography-electrospray ionisation-tandem mass spectrometry. Biomed Chromatogr 21:1172–9
   PubMed Web of Science ®Google Scholar
• Jeong S, Nguyen PD, Desta Z. (2009). Comprehensive in vitro analysis of voriconazole inhibition of eight cytochrome P450 (CYP) enzymes: major effect on CYPs 2B6, 2C9, 2C19, and 3A. Antimicrob Agent Chemother 53:541–51
   PubMed Web of Science ®Google Scholar
• Kong WM, Chik Z, Ramachandra M, et al. (2011). Evaluation of the effects of Mitragyna speciosa alkaloid extract on cytochrome P450 enzymes using a high throughput assay. Molecules 16:7344–56
   PubMed Web of Science ®Google Scholar
• Li X, Wang K, Wei W, et al. (2013). In vitro metabolism of brucine by human liver microsomes and its interactions with CYP substrates. Chem Biol Interact 204:140–3
   PubMed Web of Science ®Google Scholar
• Liu F, Yu G, Wang G, et al. (2012). An NQO1-initiated and p53-independent apoptotic pathway determines the anti-tumor effect of tanshinone IIA against non-small cell lung cancer. PLoS One 7:e42138
   Web of Science ®Google Scholar
• Liu HX, Hu Y, Liu Y, et al. (2009). Hydroxylation of tanshinone IIa in human liver microsomes is specifically catalysed by cytochrome P4502A6. Xenobiotica 39:382–90
   PubMed Web of Science ®Google Scholar
• Liu JQ, Lee TF, Miedzyblocki M, et al. (2011). Effects of tanshinone IIA, a major component of Salvia miltiorrhiza, on platelet aggregation in healthy newborn piglets. J Ethnopharmacol 137:44–9
   PubMed Web of Science ®Google Scholar
• Maione F, de Feo V, Caiazzo E, et al. (2014). Tanshinone IIA, a major component of Salvia milthorriza Bunge, inhibits platelet activation via Erk-2 signaling pathway. J Ethnopharmacol 155:1236-42
   PubMed Web of Science ®Google Scholar
• Mao S, Jin H, Bi Y, et al. (2007). Ion-pair reversed-phase HPLC method for determination of sodium tanshinone IIA sulfonate in biological samples and its pharmacokinetics and biodistribution in mice. Chem Pharm Bull 55:753–6
   PubMed Web of Science ®Google Scholar
• Murayama N, Nakamura T, Saeki M, et al. (2002). CYP3A4 gene polymorphisms influence testosterone 6beta-hydroxylation. Drug Metab Pharmacokinet 17:150–6
   PubMedGoogle Scholar
• Qin CZ, Ren X, Tan ZR, et al. (2014). A high-throughput inhibition screening of major human cytochrome P450 enzymes using an in vitro cocktail and liquid chromatography-tandem mass spectrometry. Biomed Chromatogr 28:197–203
   PubMed Web of Science ®Google Scholar
• Ring BJ, Binkley SN, Vandenbranden M, et al. (1996). In vitro interaction of the antipsychotic agent olanzapine with human cytochromes P450 CYP2C9, CYP2C19, CYP2D6 and CYP3A. Br J Clin Pharmacol 41:181–6
   PubMed Web of Science ®Google Scholar
• Sun N, Cong XM, Jiang JB, et al. (2014a). Sodium tanshinone IIA sulfonate inhibits the meq, ul49 and VP22 expression of Marek’s disease virus. Antiviral Ther 19:793–8
   PubMed Web of Science ®Google Scholar
• Sun N, Li E, Wang Z, et al. (2014b). Sodium tanshinone IIA sulfonate inhibits porcine reproductive and respiratory syndrome virus via suppressing N gene expression and blocking virus-induced apoptosis. Antiviral Ther 19:89–95
   PubMed Web of Science ®Google Scholar
• Sun N, Zhao X, Bai XY, et al. (2012). Anti-PRRSV effect and mechanism of sodium tanshinone IIA sulfonate in vitro. J Asian Nat Prod Res 14:721–8
   PubMed Web of Science ®Google Scholar
• Taavitsainen P, Juvonen R, Pelkonen O. (2001). In vitro inhibition of cytochrome P450 enzymes in human liver microsomes by a potent CYP2A6 inhibitor, trans-2-phenylcyclopropylamine (tranylcypromine), and its nonamine analog, cyclopropylbenzene. Drug Metab Dispos 29:217–22
   PubMed Web of Science ®Google Scholar
• Ueng YF, Kuo YH, Peng HC, et al. (2003). Diterpene quinone tanshinone IIA selectively inhibits mouse and human cytochrome p4501A2. Xenobiotica 33:603–13
   PubMed Web of Science ®Google Scholar
• Ueng YF, Kuo YH, Wang SY, et al. (2004). Induction of CYP1A by a diterpene quinone tanshinone IIA isolated from a medicinal herb Salvia miltiorrhiza in C57BL/6J but not in DBA/2J mice. Life Sci 74:885–96
   PubMed Web of Science ®Google Scholar
• Wang P, Zhou S, Xu L, et al. (2013). Hydrogen peroxide-mediated oxidative stress and collagen synthesis in cardiac fibroblasts: blockade by tanshinone IIA. J Ethnopharmacol 145:152–61
   PubMed Web of Science ®Google Scholar
• Wang X, Cheung CM, Lee WY, et al. (2010). Major tanshinones of Danshen (Salvia miltiorrhiza) exhibit different modes of inhibition on human CYP1A2, CYP2C9, CYP2E1 and CYP3A4 activities in vitro. Phytomedicine 17:868–75
   PubMed Web of Science ®Google Scholar
• Wei B, Li WW, Ji J, et al. (2014). The cardioprotective effect of sodium tanshinone IIA sulfonate and the optimizing of therapeutic time window in myocardial ischemia/reperfusion injury in rats. Atherosclerosis 235:318–27
   PubMed Web of Science ®Google Scholar
• Xu C, Desta Z. (2013). In vitro analysis and quantitative prediction of efavirenz inhibition of eight cytochrome P450 (CYP) enzymes: major effects on CYPs 2B6, 2C8, 2C9 and 2C19. Drug Metab Pharmacokinet 28:362–71
   PubMed Web of Science ®Google Scholar
• Yang L, Zou X, Liang Q, et al. (2007). Sodium tanshinone IIA sulfonate depresses angiotensin II-induced cardiomyocyte hypertrophy through MEK/ERK pathway. Exp Mol Med 39:65–73
   PubMed Web of Science ®Google Scholar
• Yang R, Liu A, Ma X, et al. (2008). Sodium tanshinone IIA sulfonate protects cardiomyocytes against oxidative stress-mediated apoptosis through inhibiting JNK activation. J Cardiovasc Pharmacol 51:396–401
   PubMed Web of Science ®Google Scholar
• Yang XF, Wang NP, Lu WH, Zeng FD. (2003). Effects of Ginkgo biloba extract and tanshinone on cytochrome P-450 isozymes and glutathione transferase in rats. Acta Pharmacol Sin 24:1033–8
   PubMed Web of Science ®Google Scholar
• Yu H, Subedi RK, Nepal PR, et al. (2012). Enhancement of solubility and dissolution rate of cryptotanshinone, tanshinone I and tanshinone IIA extracted from Salvia miltiorrhiza. Arch Pharm Res 35:1457–64
   PubMed Web of Science ®Google Scholar
• Zhou LP, Yao F, Luan H, et al. (2013). CYP3A4*1B polymorphism and cancer risk: a HuGE review and meta-analysis. Tum Biol 34:649–60
   PubMed Web of Science ®Google Scholar
• Zhou S, Gao Y, Jiang W, et al. (2003). Interactions of herbs with cytochrome P450. Drug Metab Rev 35:35–98
   PubMed Web of Science ®Google Scholar